Rudina Seseri
Known title: DirectorCIK: 0001744006
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
MSM: Manufacturing Growth Fuels Analyst Upside Views. A Yahoo article names MSC Industrial Direct among five stocks highlighted as U.S. manufacturing has expanded for nine straight months. SeekingAlpha notes that the company's upside may be limited relative to its current price. Another Yahoo piece points out that industrial product stocks, including MSC, have lagged peers such as W.W. Grainger this year. These reports suggest that while the sector is growing, MSC’s valuation and performance relative to peers may temper expectations.
Transaction History
| MTB | ▼ Sell | Open Market | 623 | $150K | 8/21/2026 | View on chart |
| MTB | ▲ Buy | Grant | 664 | $0 | 4/30/2026 | View on chart |
| MSM | ▼ Sell | Open Market | 1,800 | $156K | 2/2/2026 | View on chart |
| MSM | ▲ Buy | Option Exercise | 695 | $0 | 1/24/2026 | View on chart |
| MSM | ▲ Buy | Option Exercise | 50 | $0 | 1/24/2026 | View on chart |
| MSM | ▲ Buy | Option Exercise | 799 | $0 | 1/22/2026 | View on chart |
| MSM | ▲ Buy | Option Exercise | 24 | $0 | 1/22/2026 | View on chart |
| MTB | ▲ Buy | Grant | 855 | $0 | 4/30/2025 | View on chart |
| MSM | ▲ Buy | Option Exercise | 777 | $0 | 1/25/2025 | View on chart |
| MSM | ▲ Buy | Option Exercise | 50 | $0 | 1/25/2025 | View on chart |
| MSM | ▲ Buy | Option Exercise | 695 | $0 | 1/24/2025 | View on chart |
| MSM | ▲ Buy | Option Exercise | 20 | $0 | 1/24/2025 | View on chart |
| MTB | ▲ Buy | Grant | 935 | $0 | 4/30/2024 | View on chart |
| MSM | ▲ Buy | Option Exercise | 762 | $0 | 1/26/2024 | View on chart |
| MSM | ▲ Buy | Option Exercise | 56 | $0 | 1/26/2024 | View on chart |
| MSM | ▲ Buy | Option Exercise | 776 | $0 | 1/25/2024 | View on chart |
| MSM | ▲ Buy | Option Exercise | 26 | $0 | 1/25/2024 | View on chart |
| MTB | ▼ Sell | Open Market | 700 | $83K | 5/17/2023 | View on chart |
| MTB | ▲ Buy | Grant | 954 | $0 | 4/28/2023 | View on chart |
| MSM | ▲ Buy | Option Exercise | 748 | $0 | 1/27/2023 | View on chart |
| MSM | ▲ Buy | Option Exercise | 56 | $0 | 1/27/2023 | View on chart |
| MSM | ▲ Buy | Option Exercise | 761 | $0 | 1/26/2023 | View on chart |
| MSM | ▲ Buy | Option Exercise | 28 | $0 | 1/26/2023 | View on chart |
| MSM | ▲ Buy | Option Exercise | 42 | $0 | 9/8/2022 | View on chart |
| MSM | ▲ Buy | Option Exercise | 362 | $0 | 9/8/2022 | View on chart |
| MTB | ▲ Buy | Grant | 721 | $0 | 4/29/2022 | View on chart |
| MSM | ▲ Buy | Option Exercise | 748 | — | 1/27/2022 | View on chart |
| MSM | ▲ Buy | Option Exercise | 26 | — | 1/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MTB Q3 Earnings Beat on NII, Stock Slides on Cost Concerns
M&T Bank reported third‑quarter earnings that topped analysts’ expectations, driven by higher net interest income. The results also highlighted rising expenses, which pushed the share price lower after the release. Analysts noted that the upside case remains intact despite the cost pressure. The stock is currently near its recent support level.
MTB Q3 Earnings Beat on NII, Stock Slides on Cost Concerns. M&T Bank reported third‑quarter earnings that topped analysts’ expectations, driven by higher net interest income. The results also highlighted rising expenses, which pushed the share price lower after the release. Analysts noted that the upside case remains intact despite the cost pressure. The stock is currently near its recent support level.